162
Views
3
CrossRef citations to date
0
Altmetric
Mechanisms

Serum IFNγ–induced protein 10 (IP10/CXCL10): association with asthma exacerbations and severity in children

, MD, , MD, , MSc & , MDORCID Icon
Pages 2135-2142 | Received 01 Mar 2021, Accepted 24 Oct 2021, Published online: 27 Dec 2021

References

  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2019. Available from: www.ginasthma.org.
  • Gern JE. Virus/allergen interaction in asthma exacerbation. Ann Am Thorac Soc. 2015;12(Suppl 2):S137–S143.
  • Li H, Wang H, Sokulsky L, Liu S, Yang R, Liu X, Zhou L, Li J, Huang C, Li F, et al. Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation. J Allergy Clin Immunol. 2021;147(3):941–954. doi:10.1016/j.jaci.2020.09.032.
  • Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50(4):975–991. doi:10.1016/j.immuni.2019.03.018.
  • Korpi-Steiner NL, Valkenaar SM, Bates ME, Evans MD, Gern JE, Bertics PJ. Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy. 2010;40(8):1203–1213. doi:10.1111/j.1365-2222.2010.03546.x.
  • Metzemaekers M, Vanheule V, Janssens R, Struyf S, Proost P. Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands. Front Immunol. 2017;8:1970. doi:10.3389/fimmu.2017.01970.
  • Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011;89(2):207–215. doi:10.1038/icb.2010.158.
  • Gauthier M, Chakraborty K, Oriss TB, Raundhal M, Das S, Chen J, Huff R, Sinha A, Fajt M, Ray P, et al. Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias. JCI Insight. 2017;2(13):e94580. doi:10.1172/jci.insight.94580.
  • Campbell D, Gangur V, Simons FE, HayGlass KT. Allergic humans are hypo‐responsive to CXCR3 chemokines in a Th1 immunity‐promoting loop. FASEB J. 2004;18(2):1–9. doi:10.1096/fj.02-0908fje.
  • Takaku Y, Soma T, Uchida Y, Kobayashi T, Nakagome K, Nagata M. CXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study. Asthma Res Pract. 2016;2(1):6. doi:10.1186/s40733-016-0021-y.
  • Ying S, O’Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, Robinson D, Zhang G, Zhao J, Lee TH, et al. Corrigan: thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of TH2-attracting chemokines and disease severity. J Immunol. 2005;174(12):8183–8190. doi:10.4049/jimmunol.174.12.8183.
  • Arikoglu T, Akyilmaz E, Yildirim DD, Batmaz SB, Ulger ST, Aslan G, Kuyucu S. The relation of innate and adaptive immunity with viral-induced acute asthma attacks: focusing on IP-10 and cathelicidin. Allergol Immunopathol. 2017;45(2):160–168. doi:10.1016/j.aller.2016.07.003.
  • Seumois G, Ramírez-Suástegui C, Schmiedel BJ, Liang S, Peters B, Sette A, Vijayanand P. Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma. Sci Immunol. 2020;5(48):eaba6087. doi:10.1126/sciimmunol.aba6087.
  • Akiki Z, Rava M, Diaz Gil O, Pin I, Le Moual N, Siroux V, Guerra S, Chamat S, Matran R, Fitó M, et al. Serum cytokine profiles as predictors of asthma control in adults from the EGEA study. Respir Med. 2017;125:57–64. doi:10.1016/j.rmed.2017.03.002.
  • Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 2015;15(1):57–65. doi:10.1038/nri3786.
  • Hastie AT, Mauger DT, Denlinger LC, Coverstone A, Castro M, Erzurum S, Jarjour N, Levy BD, Meyers DA, Moore WC, et al. Mixed sputum granulocyte longitudinal impact on lung function in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2021;203(7):882–892. doi:10.1164/rccm.202009-3713OC.
  • Raundhal M, Morse C, Khare A, Oriss TB, Milosevic J, Trudeau J, Huff R, Pilewski J, Holguin F, Kolls J, et al. High IFN-γ and low SLPI mark severe asthma in mice and humans. J Clin Invest. 2015;125(8):3037–3050. doi:10.1172/JCI80911.
  • Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, et al. After asthma: redefining airways diseases. The Lancet. 2018;391(10118):350–400. doi:10.1016/S0140-6736(17)30879-6.
  • Kostakou E, Kaniaris E, Filiou E, Vasileiadis I, Katsaounou P, Tzortzaki E, Koulouris N, Koutsoukou A, Rovina N. Acute severe asthma in adolescent and adult patients: current perspectives on assessment and management. J Clin Med. 2019;8(9):1283. doi:10.3390/jcm8091283.
  • Comberiati P, Di Cicco ME, D’Elios S, Peroni DG. How much asthma is atopic in children? Front Pediatr. 2017;5:122. doi:10.3389/fped.2017.00122.
  • Bochner BS, Hudson SA, Xiao HQ, Liu MC. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol. 2003;112(5):930–934. doi:10.1016/j.jaci.2003.08.012.
  • Muehling LM, Heymann PW, Wright PW, Eccles JD, Agrawal R, Carper HT, Murphy DD, Workman LJ, Word CR, Ratcliffe SJ, et al. Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma. J Allergy Clin Immunol. 2020;146(3):555–570. doi:10.1016/j.jaci.2020.03.037.
  • Redhu NS, Saleh A, Shan L, Gerthoffer WT, Kung SK, Halayko AJ, Lamkhioued B, Gounni AS. Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcεRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One. 2009;4(7):e6153. doi:10.1371/journal.pone.0006153.
  • Suzukawa M, Matsumoto H, Ohshima N, Tashimo H, Asari I, Tajiri T, Niimi A, Nagase H, Matsui H, Kobayashi N, et al. Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics’ responsiveness to omalizumab. Respir Med. 2018;134:95–102. doi:10.1016/j.rmed.2017.12.002.
  • Ghebre MA, Pang PH, Desai D, Hargadon B, Newby C, Woods J, Rapley L, Cohen SE, Herath A, Gaillard EA, et al. Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum. BMC Pulm Med. 2019;19(1):144. doi:10.1186/s12890-019-0906-7.
  • Nakagome K, Nagata M. Involvement and possible role of eosinophils in asthma exacerbation. Front Immunol. 2018;9:2220. doi:10.3389/fimmu.2018.02220.
  • Demarche SF, Schleich FN, Paulus VA, Henket MA, Van Hees TJ, Louis RE. Asthma control and sputum eosinophils: a longitudinal study in daily practice. J Allergy Clin Immunol.: In Prac. 2017;5(5):1335–1343. doi:10.1016/j.jaip.2017.01.026.
  • Takaku Y, Nakagome K, Kobayashi T, Hagiwara K, Kanazawa M, Nagata M. IFN-γ-inducible protein of 10 kDa upregulates the effector functions of eosinophils through β2 integrin and CXCR3. Respir Res. 2011;12(1):138–139. doi:10.1186/1465-9921-12-138.
  • Noguchi T, Nakagome K, Kobayashi T, Ueda Y, Uchida Y, Soma T, Nakamoto H, Nagata M. Effect of LTRA on IP-10-induced eosinophil adhesion to ICAM-1. Allergology International. 2016;65(Suppl 1):S62–S64. doi:10.1016/j.alit.2016.04.015.
  • Carlsten C, Blomberg A, Pui M, Sandstrom T, Wong SW, Alexis N, Hirota J. Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals: a controlled human exposure study. Thorax. 2016;71(1):35–44. doi:10.1136/thoraxjnl-2015-207399.
  • Kantor DB, Stenquist N, McDonald MC, Schultz BJ, Hauptman M, Smallwood CD, Nelson KA, Perzanowski MS, Matsui EC, Phipatanakul W, Hirschhorn JN. Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol. 2016;138(5):1467–1471. doi:10.1016/j.jaci.2016.04.044.
  • Shariff S, Shelfoon C, Holden NS, Traves SL, Wiehler S, Kooi C, Proud D, Leigh R. Human rhinovirus infection of epithelial cells modulates airway smooth muscle migration. Am J Respir Cell Mol Biol. 2017;56(6):796–803. doi:10.1165/rcmb.2016-0252OC.
  • Shelfoon C, Shariff S, Traves SL, Kooi C, Leigh R, Proud D. Chemokine release from human rhinovirus-infected airway epithelial cells promotes fibroblast migration. J Allergy Clin Immunol. 2016;138(1):114–122. doi:10.1016/j.jaci.2015.12.1308.
  • Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545–554. doi:10.1183/09031936.00155307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.